摘要
弥散性血管内凝血（DIC）是在某些疾病基础上，致病因素引起体内凝血系统激活、血小板活化、纤维蛋白沉积，导致弥散性血管内微血栓形成；继之多种凝血因子和血小板消耗性降低；在凝血系统激活的同时，纤溶系统亦被激活，或继发于凝血异常，导致纤溶亢进。临床上以出血、栓塞、微循环障碍和微血管病性溶血等为主要表现，严重时可导致器官功能衰竭。
出处
《中国小儿急救医学》
CAS
2008年第5期405-407,共3页
Chinese Pediatric Emergency Medicine
参考文献17
-
1Bergqvist D. Low molecular weight heparins. J Intern Med, 1996, 240(1) : 63-72.
-
2Russell DH, Graham FP. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive. Sem Thromb Hemost, 2004, 30 ( Suppl 1 ) : 11-23.
-
3Kienast J, Juersc M, Wiedermann J, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. Thromb Haemost, 2006, 4( 1 ) : 90-97.
-
4Bernard GR, Vincent AL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, 2001, 344(10) : 699-709.
-
5Joyce DE, Gelbert L, Ciaccia A, et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem, 2001, 276 ( 11 ) : 11199-11203.
-
6Bajaj MS, Birktoft J J, Steer SA, et al. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost, 2001, 864 (4) :959.
-
7Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin(recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA, 2003, 290 (1) : 238- 247.
-
8Yao Z, Foster PA, Gross GJ. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock, 1994, 43(3) : 107-114.
-
9Kobayashi T, Terao T, Maki M, et al. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost, 2001,27 (2) :161-167.
-
10Levi M, de Jonge E, van der Poll T. Plasma and plasma components in the management of disseminated intravascular coagulation. Best Pratt Res Clin Haematol, 2006, 19 ( 1 ) : 127-142.
同被引文献5
-
1胡亚美 江载芳.诸福棠实用儿科学[M] 7版[M].北京:人民卫生出版社,2002.698-705.
-
2沈晓明,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:449-450.
-
3徐南平,吴卫萍,林敏,钟立群,朱友荣,黄雪英.急危重患儿弥散性血管内凝血的早期监测研究[J].中国小儿急救医学,2008,15(1):32-35. 被引量：2
-
4陈伟明,陆铸今,陆国平,张灵恩.血浆置换在儿童危重症中的应用[J].临床儿科杂志,2009,27(7):655-658. 被引量：7
-
5陈植,周楠,张桂菊,陈春红,沈颖.血浆置换治疗儿童神经系统疾病六例临床分析[J].中国小儿急救医学,2009,16(4):387-388. 被引量：6
-
1宋善俊.弥散性血管内凝血诊疗指南[J].继续医学教育,2006,20(4):9-15. 被引量：15
-
2郭秋娥,高瑞利,陈立峰.以神经系统症状为首发表现的血栓性血小板减少性紫癜误诊1例[J].临床荟萃,2009,24(18):1640-1640. 被引量：1
-
3卢博,刘泽林,王欣,金梦迪.非典型血栓性血小板减少性紫癜临床分析[J].内科急危重症杂志,2015,21(3):213-216. 被引量：4
-
4艾拉努尔.重度妊高征合并HeLLP综合征1例[J].中华今日医学杂志,2003,3(2):73-73.
-
5刘荣华.低分子肝素治疗急性冠脉综合征的临床观察[J].现代医药卫生,2008,24(4):552-552.
-
6祝汉林.低分子肝素治疗急性冠脉综合征的疗效观察[J].中国伤残医学,2009,17(4):54-54. 被引量：1
-
7史旭波,胡大一.急性冠状动脉综合征抗栓治疗进展[J].中国心血管病研究,2003,1(1):75-77. 被引量：25
-
8胡豫,王华芳.弥散性血管内凝血诊治进展[J].中国实用内科杂志,2008,28(10):820-823. 被引量：7
-
9韦夙,黄锦雄,叶红.血栓性血小板减少性紫癜6例临床分析[J].华夏医学,2011,24(3):309-312. 被引量：3
-
10何涛,李黔宁.以肌无力为首发表现的血栓性血小板减少性紫癜误诊1例[J].中国医药指南,2012,10(25):617-618. 被引量：1
